Numbers, Facts and Trends Shaping Your World
Newsletters Press Donate My Account Contacted By Us?
Pew Research Center Logo

Read our research on: Gun Policy | International Conflict | Election 2024

Pew Research Center Logo
Research Topics
All PublicationsMethodsShort ReadsTools & ResourcesExpertsAbout
Topics
Politics & PolicyInternational AffairsImmigration & MigrationRace & EthnicityReligionAge & GenerationsGender & LGBTQ
Family & RelationshipsEconomy & WorkScienceInternet & TechnologyNews Habits & MediaMethodological ResearchFull topic list
Regions & Countries
Asia & the PacificEurope & RussiaLatin AmericaMiddle East & North AfricaNorth AmericaSub-Saharan AfricaMultiple Regions / Worldwide
Formats
FeaturesFact SheetsVideosData Essays
Research Topics
Topics
Politics & PolicyInternational AffairsImmigration & MigrationRace & EthnicityReligionAge & GenerationsGender & LGBTQFamily & RelationshipsEconomy & WorkScienceInternet & TechnologyNews Habits & MediaMethodological ResearchFull topic list
Regions & Countries
Asia & the PacificEurope & RussiaLatin AmericaMiddle East & North AfricaNorth AmericaSub-Saharan AfricaMultiple Regions / Worldwide
Formats
FeaturesFact SheetsVideosData Essays
All PublicationsMethodsShort ReadsTools & ResourcesExpertsAboutNewslettersPressMy AccountContacted By Us?
DONATE

Read our research on: Gun Policy | International Conflict | Election 2024

Home Research Topics Science Science Issues Medicine & Health
Pew Research CenterFebruary 22, 2024
How Americans View Weight-Loss Drugs and Their Potential Impact on Obesity in the U.S.

Americans more likely to view Ozempic, similar drugs as good weight-loss options for people with obesity than for people without a weight-related condition

← Prev Page
You are reading page1Page2Page3Page4Page5Page6
Next Page →
Americans more likely to view Ozempic, similar drugs as good weight-loss options for people with obesity than for people without a weight-related condition

Post Infographics

How Americans View Weight-Loss Drugs and Their Potential Impact on Obesity in the U.S.
Americans more likely to view Ozempic, similar drugs as good weight-loss options for people with obesity than for people without a weight-related condition
Modest expectations for the impact Ozempic and other similar drugs will have on obesity in America
65% of Americans say willpower alone is not enough for most people to lose weight and keep it off
Views on weight loss and willpower by respondents’ description of their own weight
Diet and exercise top public’s list of factors affecting a person’s weight; many also cite stress and anxiety
Women are more likely than men to say stress and anxiety affects a person’s weight a great deal

Pew Research Center
1615 L St. NW, Suite 800
Washington, DC 20036
USA
(+1) 202-419-4300 | Main
(+1) 202-857-8562 | Fax
(+1) 202-419-4372 | Media Inquiries

Research Topics
Politics & PolicyInternational AffairsImmigration & MigrationRace & EthnicityReligionAge & GenerationsGender & LGBTQ
Family & RelationshipsEconomy & WorkScienceInternet & TechnologyNews Habits & MediaMethodological ResearchFull topic list
Follow Us
Email Newsletters Instagram Twitter LinkedIn YouTube RSS

About Pew Research Center Pew Research Center is a nonpartisan fact tank that informs the public about the issues, attitudes and trends shaping the world. It conducts public opinion polling, demographic research, media content analysis and other empirical social science research. Pew Research Center does not take policy positions. It is a subsidiary of The Pew Charitable Trusts.

Copyright 2024 Pew Research Center About Terms & Conditions Privacy Policy Cookie Settings Reprints, Permissions & Use Policy Feedback Careers